SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Trading 2.8% Higher – Still a Buy?

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPHGet Free Report) shot up 2.8% during trading on Thursday . The company traded as high as $67.17 and last traded at $67.16. Approximately 87,085 shares changed hands during mid-day trading, an increase of 5% from the average session volume of 83,059 shares. The stock had previously closed at $65.32.

SPDR S&P Pharmaceuticals ETF Stock Performance

The stock has a market cap of $409.68 million, a P/E ratio of 14.28 and a beta of 0.58. The firm has a 50-day simple moving average of $59.68 and a two-hundred day simple moving average of $57.28.

Hedge Funds Weigh In On SPDR S&P Pharmaceuticals ETF

Several institutional investors and hedge funds have recently modified their holdings of XPH. Turtle Creek Wealth Advisors LLC acquired a new stake in SPDR S&P Pharmaceuticals ETF in the 1st quarter worth about $26,000. Western Wealth Management LLC acquired a new position in shares of SPDR S&P Pharmaceuticals ETF during the 1st quarter worth approximately $34,000. Advisory Services Network LLC acquired a new position in shares of SPDR S&P Pharmaceuticals ETF during the 3rd quarter worth approximately $34,000. Fifth Third Bancorp bought a new position in shares of SPDR S&P Pharmaceuticals ETF during the first quarter worth approximately $39,000. Finally, Team Financial Group LLC bought a new position in shares of SPDR S&P Pharmaceuticals ETF during the fourth quarter worth approximately $56,000.

About SPDR S&P Pharmaceuticals ETF

(Get Free Report)

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Read More

Receive News & Ratings for SPDR S&P Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.